During the past decade, Cape Fear Heart Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cape Fear Heart Associates" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cape Fear Heart Associates" are "Cardiomyopathies" (1 trials), "Cardiovascular Diseases" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Gender" (1 trials) and "Implantable Defibrillator User" (1 trials). Many other conditions were trialed in "Cape Fear Heart Associates" in a lesser frequency.

Most popular intervention types in "Cape Fear Heart Associates" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Intense Education Intervention" (1 trials) and "TPD RAMWare" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cape Fear Heart Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Cape Fear Heart Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cape Fear Heart Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cape Fear Heart Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".